Devicare, one of the leading biotechnology companies in urology in Spain and a CataloniaBio & HealthTech  member, presents to the market the first app designed specifically for patients with renal lithiasis. myLit-Control®  App allows patients to make a personalized follow-up of their pathology through daily monitoring, access to educational content, the possibility of receiving discounts on the purchase of products and participating in challenges aimed at changing their habits.

This project  begins with the entry of Advanced Medtech Holdings into the capital of Devicare  in 2020, with the aim of promoting the digital area of Devicare. In these two years of pandemic, biotechnology has been intensely developing a unique application in the market to help patients with kidney stones. This application, which can also be connected via Bluetooth® with the Lit-Control® pH Meter medical device, has at the time of its launch three scientific articles published in the journal Spanish Archives of Urology.

myLit-Control App is a free tool accessible to any kidney stone patient. "At Devicare we are confident that the prevention of kidney stones can be achieved to a large extent with a change in the lifestyle of patients, along with a control and monitoring of treatment, water consumption and urinary pH" in words by José  Buela, Product Manager of myLit-Control® App.

According to Rosendo Garganta, CEO of Devicare, “myLit-Control® App is a further step in our commitment to kidney stones treatmenr. Together with other products in the Lit-Control® family, and the collaboration of our fellow urologists, we aim to revolutionize the way this pathology is treated in the world. Devicare has just begun a new era in the management of patients with kidney stones.”